Selumetinib in Chinese Paediatric With Post-operative NF1-PNs, PhaseⅡ, Double-Blinded, Placebo-Controlled Study
Clinical trial NCT05825365 · WITHDRAWN
Trial details
- NCT number
- NCT05825365
- Sponsor
- AstraZeneca
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-31
- Primary completion
- 2026-06-30
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.